Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes-Reference-Cited by-同舟云学术

Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes

Published:2020-02 Issue:1 Volume:44 Page:61-67
ISSN:1499-2671
Container-title:Canadian Journal of Diabetes
language:en
Short-container-title:Canadian Journal of Diabetes

Author:

Woo Vincent C.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. IDF Diabetes Atlas,2017

2. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study;Booth;Lancet,2006

3. Diabetes and mortality following acute coronary syndromes;Donahoe;JAMA,2007

4. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients;Valle;Eur J Echocardiogr,2006

5. Center for Drug Evaluation and Research. Diabetes Mellitus -- Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes. U.S. Department of Health and Human Services,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eight weeks of treatment with mineralocorticoid receptor blockade does not alter vascular function in individuals with and without type 2 diabetes;Physiological Reports;2024-04

2. Highly Stereoselective Synthesis of Bis-C-ferrocenyl Glycosides via Palladium-Catalyzed Directed C–H Glycosylation;Organic Letters;2023-05-26

3. Sodium-glucose cotransporter-2 inhibitors and cardiovascular safety profile: a pharmacovigilance analysis of the US food and drug administration adverse event reporting system;Expert Opinion on Drug Safety;2023-05-26

4. C–H Activation for the Synthesis of C1‐(hetero)aryl Glycosides;Transition‐Metal‐Catalyzed C‐H Functionalization of Heterocycles;2023-03-25

5. Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions;Journal of Thrombosis and Thrombolysis;2022-11-17